|
- Immunoaugmentative therapy (IAT) has been used to treat various types of cancer. Treatment is only available at IAT centers, which have been established in locations including the Bahamas, Germany, and Mexico. Patients can only receive immunoaugmentative therapy (IAT) if they have been diagnosed with cancer. Then, the patient is screened to determine whether or not IAT is appropriate for his/her specific condition. Healthcare providers will take into consideration the type and severity of the cancer, as well as the patient's overall health. IAT appears to be more effective in patients who have not received chemotherapy (a cancer treatment).
- During therapy, patients may receive anywhere from one to 12 injections a day. In general, treatment generally lasts about 10–12 weeks. Patients typically return to the clinic for about two weeks, every four to six months. A healthcare provider measures the patient's response to treatment throughout IAT.
 |
Learn
